In the BioHarmony Drug Report Database

"Preview" Icon

Lipegfilgrastim

Lonquex (lipegfilgrastim) is a protein pharmaceutical. Lipegfilgrastim was first approved as Lonquex on 2013-07-25. It has been approved in Europe to treat neutropenia.

 

Trade Name

 

Lonquex
 

Common Name

 

lipegfilgrastim
 

ChEMBL ID

 

CHEMBL4594230
 

Indication

 

neutropenia
 

Drug Class

 

Pegylated compounds; colony-stimulating factors: granulocyte colony-stimulating factors (G-CSF)

Image (chem structure or protein)

Lipegfilgrastim structure rendering